HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The ventilatory response to incremental exercise: is it one or two breakpoints?

Abstract
The primary objective of this study was to determine if the ventilatory (&OV0312;E) breakpoint during incremental exercise to fatigue is best represented by a single breakpoint (BP1), double breakpoint (BP2), or an exponential function (EXP) exhibiting no BP. A secondary objective was to determine if visual assessment of the BP was valid and reliable. Subjects (n = 49) were both men (n = 12) and women (n = 37) who identified either running (n = 31) or triathlon (n = 18) as their primary sport. Subjects completed a maximal oxygen test on a motor-driven treadmill according to a modified Bruce protocol. The difference in mean square error (MSE) for BP1 (4.91 ± 3.35 L) was slightly but significantly (p < 0.05) greater than in MSE for BP2 (2.75 ± 1.7 L) for VE. Mean square error for EXP (7.85 ± 5.1 L) was significantly greater (p < 0.05) than BP1 and BP2. Visual assessment of VE on scatterplots produced poor validity, with a mean of 71.7% being misclassified compared to the computer model. Both interevaluator reliability (30.6% agreement) and intraevaluator reliability (59.7% agreement) were low. From the results of this study, it is concluded that (a) VE exhibits a BP2 model rather than BP1 or EXP and (b) visual assessment of BP is both invalid and unreliable.
AuthorsDaniel G Carey, German J Pliego, John L Rohwer
JournalJournal of strength and conditioning research (J Strength Cond Res) Vol. 24 Issue 10 Pg. 2840-5 (Oct 2010) ISSN: 1533-4287 [Electronic] United States
PMID20885203 (Publication Type: Journal Article)
Topics
  • Adult
  • Anaerobic Threshold
  • Exercise (physiology)
  • Fatigue (physiopathology)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Pulmonary Ventilation (physiology)
  • Running (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: